Dabrafenib and trametinib in patients with tumors with BRAFV600E mutations: Results of the NCI-MATCH trial subprotocol H

April K.S. Salama, Shuli Li, Erin R. Macrae, Jong In Park, Edith P. Mitchell, James A. Zwiebel, Helen X. Chen, Robert J. Gray, Lisa M. McShane, Larry V. Rubinstein, David Patton, P. Mickey Williams, Stanley R. Hamilton, Deborah K. Armstrong, Barbara A. Conley, Carlos L. Arteaga, Lyndsay N. Harris, Peter J. O'Dwyer, Alice P. Chen, Keith T. Flaherty

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Dabrafenib and trametinib in patients with tumors with BRAF<sup>V600E</sup> mutations: Results of the NCI-MATCH trial subprotocol H'. Together they form a unique fingerprint.

Medicine & Life Sciences